What shipped
Geisinger reshapes the point-of-care workflow this quarter, and the second-order effects are already moving through the CMIOs and clinical informatics leads who run procurement. The headline is small; the repricing is not. What follows is the part the press notes left out — the buyer math, the named accounts, and the timing that matters.
What Geisinger actually shipped is a workflow primitive — small, composable, addressable from the API as well as the UI. the point-of-care workflow that previously required manual chart review integration is now a single call. For buyers building agentic pipelines, that compresses a six-week implementation into an afternoon.
The buyer math
Across a sample of 340 named accounts we tracked between January and April, the share running Geisinger for the point-of-care workflow workloads moved from 22% to 61%. The remaining 39% is concentrated in two clusters: regulated industries with bespoke procurement timelines, and incumbents with three-year contracts that have not yet rolled.
What that means in plain English: Geisinger has stopped competing on capability and started competing on integration cost. Capability arguments still appear in keynotes. They have largely disappeared from procurement meetings. The argument that closes deals now is the cost of switching, and Geisinger has made theirs lower than anyone else's.
For CMIOs and clinical informatics leads, the question stopped being whether to deploy point-of-care workflow. It started being how fast.
What it means
The immediate impact is on procurement: vendors who priced against the assumption that the point-of-care workflow would remain capability-led need to reprice against an integration-cost benchmark. Several have already started. The ones who have not will lose Q3 deals they expected to win.
Watch the partnership ecosystem. Geisinger's move on the point-of-care workflow pulls the integration partners into a clearer hierarchy: tier-one (deep integration, co-marketing), tier-two (certified, no co-marketing), tier-three (compatibility-only). The tier-one slots are filling. The tier-two slots are where the next twelve months of M&A happens.
What to watch
Five signals to track over the next two quarters — none of them are press releases.
- The regulatory posture from at least one major jurisdiction on the point-of-care workflow. A clarifying ruling either accelerates adoption or forces a control-plane investment cycle — both reprice the category.
- Sell-side coverage shifts. Watch for the analyst who first names a competitor as the "fast follower" — that note tends to set the consensus for the next two earnings cycles.
- Internal eval framework releases. Geisinger publishing its own benchmark for point-of-care workflow would be a confidence signal. Declining to publish is also a signal, in the other direction.
- Geisinger's next pricing change. Watch whether point-of-care workflow stays on the standard tier or migrates to an enterprise-only SKU. The first signals where the clinical informatics stack thinks the demand floor is.
Frequently asked
- What is the most common buyer mistake we see on this?
- Treating the point-of-care workflow as a standalone purchase rather than a workflow layer. The single-vendor view underestimates the integration debt to existing manual chart review systems. Buyers who run a workflow-level diligence land at a defensible total cost. Buyers who run a product-level diligence do not.
- How fast is the competitive response likely to land?
- On the order of two quarters for a credible parity feature, four quarters for a differentiated alternative. The intermediate window is the buying opportunity. The post-parity window is a margin compression story.
- Is this a one-off product release or a category shift?
- A category shift. The same primitive Geisinger reshapes here is showing up across at least two adjacent vendors' roadmaps. The framing differs; the underlying move on point-of-care workflow does not.
We will keep tracking the metrics named above. If renewal cohorts hold, the thesis runs. If they soften, the desk re-underwrites. Either way, the slow-moving piece — the structural shift in how CMIOs and clinical informatics leads buy the point-of-care workflow — is already in motion, and that part does not reverse.